OmniAb to Participate in Three Investor Conferences in November

On October 16, 2025 OmniAb, Inc. (NASDAQ: OABI) reported that management will be participating in three investor conferences during the month of November.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2025 Truist Securities BioPharma Symposium, November 6 at the Lotte New York Palace Hotel. Matt Foehr, Chief Executive Officer, will participate in one-on-one meetings with investors on Thursday, November 6 th.
Stifel 2025 Healthcare Conference, November 11-13 at the Lotte New York Palace Hotel. Kurt Gustafson, Chief Financial Officer, will participate in one-on-one meetings with investors on Wednesday, November 12 th.
Jefferies Global Healthcare Conference – London, November 17-20 at the Waldorf Hilton. Matt Foehr, Chief Executive Officer, will present a corporate overview on Wednesday, November 19 th at 8:00 a.m. GMT and will hold one-on-one and small-group meetings with investors on November 18-19.

(Press release, OmniAb, OCT 16, 2025, View Source [SID1234656710])